About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Texas | 1,133 Studies

Clinical Trials LymphomaTexas

Lymphoma Clinical Trials in Texas

Find 1,133 clinical trials for lymphoma near Texas. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 421-440 of 1,133 trials

CompletedPegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)This pilot clinical trial studies the side effects of pegaspargase when given together with combination chemotherapy in treating patients with newly diagnosed high-risk acute…NCT00866307·Phoenix, Arizona and 27 others

PreviousPage 22 of 57Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesThis is a Phase 1 dose escalation study to determine the maximum tolerated dose and the dose limiting toxicities of SB1518 when given alone once daily by mouth to subjects with…NCT00741871·Houston, Texas

RecruitingStudy of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaThe goal of this study is to test SIRPant-M (RB-1355) , an autologous cell therapy, alone or in combination with focal external-beam radiotherapy in participants with relapsed or…NCT05967416·Duarte, California and 2 others

TerminatedA Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLLThis is a Phase 1, open-label, multicenter study.NCT05515406·Santa Monica, California and 10 others

RecruitingA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic LeukemiaThe researchers are doing this study to find out whether PK-targeted fludarabine is an effective Lymphodepletion (LD) chemotherapy approach for people with relapsed/refractory…NCT07223021·New York, New York and 6 others

RecruitingStudy of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell MalignanciesThis study is testing Allo-QuadCAR01-T, a new off-the-shelf CAR-T therapy for people with hard-to-treat B-cell cancers.NCT07284433·Chicago, Illinois and 12 others

CompletedRituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaThe goal of this clinical research study is to learn if chemotherapy given with rituximab, followed by Ibritumomab tiuxetan (Zevalin), and then followed by rituximab can help to…NCT00290511·Houston, Texas

SuspendedA Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCLThis is a Phase 1/2 study to test the safety, tolerability, and efficacy of the investigational agent MT-101 in patients with T cell Lymphoma.NCT05138458·Duarte, California and 5 others

CompletedA Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative ColitisThe purpose of the study is to evaluate dose response of JNJ-54781532 in participants with moderately to severely active ulcerative colitis (UC).NCT01959282·La Jolla, California and 96 others

TerminatedStudy to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisStudy B7451005 is a Phase 2 study which will assess the efficacy and safety of PF-04965842 in patients with moderate to severe psoriasis.NCT02201524·Birmingham, Alabama and 44 others

TerminatedA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesThe purpose of this study is to evaluate the safety, tolerability, dose-limiting toxicities (any harmful effect of a drug) (DLT), maximum tolerated dose (MTD), recommended Phase 2…NCT02454270·Detroit, Michigan and 19 others

TerminatedSYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular LymphomaThis study evaluates the safety and efficacy of combining the EZH2 inhibitor tazemetostat with rituximab in R/R FL subjects previously treated with at least 2 standard prior…NCT04762160·Birmingham, Alabama and 19 others

CompletedMismatched Transplantation Using High-dose Post-transplant CyclophosphamideThe goal of this clinical research study is to learn about the safety of giving a stem cell transplant from a tissue-mismatched donor, followed by cyclophosphamide, to patients…NCT01010217·Houston, Texas

Active not recruitingPhase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)This is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic…NCT04150497·Birmingham, Alabama and 19 others

RecruitingStudy of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.This is a Phase 1, multi-center, open-label study with a dose-escalation phase (Phase 1a) and a cohort expansion phase (Phase 1b), to evaluate the safety, tolerability, and PK…NCT04771572·Chicago, Illinois and 7 others

Active not recruitingAllogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive LymphomasThis study involved patients that have a cancer called diffuse large B cell lymphoma (DLBCL), NK and T cell lymphomas (NK/TL) or classical Hodgkin lymphoma (cHL) (hereafter these…NCT04288726·Houston, Texas and 1 other

Active not recruitingSafety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL PatientsThis is an open-label, multicentre study too Evaluate the Safety and Pharmacokinetics of a Modified Tafasitamab IV Dosing Regimen Combined with Lenalidomide (LEN) in Patients with…NCT05222555·Morristown, New Jersey and 61 others

CompletedA Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's LymphomaTo estimate the response rate, response duration, clinical benefit, and toxicity of mitoguazone dihydrochloride (MGBG) in patients with AIDS-related refractory or relapsing…NCT00002348·San Antonio, Texas

CompletedA Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsThis study will be a Phase I/II, open-label, non-randomized, dose-finding trial conducted at multiple clinical centers.NCT01262235·Scottsdale, Arizona and 7 others

Active not recruitingStudy of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat LymphomaThis is a Phase 1b study consisting of 2 parts: a dose escalation (Part 1) of CC-220 or CC-99282 added to the standard R-CHOP-21 regimen for first-line treatment of a-BCL.NCT04884035·Birmingham, Alabama and 35 others

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia